Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Article | November 09, 2009

Patent Reform Deja Vu

Article | October 13, 2009

Eastern District of Texas Disclosures: The Texas Four Step

Blog | October 06, 2009

FDA at the border: Import and Export Regulations for Medical Devices

Blog | August 13, 2009

Copyright Ownership of Voluntary Consensus Standards

Article | June 12, 2009

New State Laws Create Challenges for Retailers in Safeguarding Customer Data

Article | May 28, 2009

The Bright Side of Nuclear Winter: Opportunities in the New, New Economy

Article | May 21, 2009

ReExamination Request: To File or Not to File?

Article | May 11, 2009

Generics Behaving Badly: Carve Outs, Off-Label Uses

Article | March 31, 2009

Protecting New Investments in Old Drugs

Article | February 18, 2009

Prior User vs. Federal Registrant: Whose Mark Is It, Anyway?

Blog | January 26, 2009

Don't be confused about whether your trademark is used

Blog | January 21, 2009

Drug Labels: The New Orange Book